Nurse-Practitioner Sentenced In High Profile Pill Mill Case
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Nurse-Practitioner Sentenced In High Profile Pill Mill Case

Nurse-Practitioner Sentenced In High Profile Pill Mill Case

April 24, 2017
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Public Information Officer
Phone Number: 571-362-2805

Justin Palmer Forged Physician’s Signatures on Prescriptions at Least 25,000 Times

MOBILE, Ala. - A former nurse practitioner, Thomas “Justin” Palmer, has been sentenced to 30 months in federal prison for his role in the operation of a massive pill mill run by Dr. Xiulu Ruan and Dr. John Patrick Couch, announced DEA Assistant Special Agent-in-Charge Bret Hamilton and Acting United States Attorney Steve Butler of the Southern District of Alabama. 

Following service in the United States Navy Palmer began working as a registered nurse at hospitals in southern Alabama. He then went back to school and earned a Master’s degree in nursing. Upon completion, Palmer was hired by Physicians Pain Specialists of Alabama which was co-owned and operated by Dr. Ruan and Dr. Couch. Palmer originally worked under both doctors, however, after about six months Palmer began to work for Dr. Couch exclusively. While working for Dr. Couch, Palmer knowingly and intentionally conspired to prescribe various controlled substances outside the usual course of professional practice and not for a legitimate medical purpose. This included the prescribing of Subsys and Abstral - both of which are brand name forms of instant release fentanyl, a Schedule II Controlled Substance.
 
During the recent trial of Dr. Ruan and Dr. Couch, Palmer testified that he regularly saw patients without any oversight from a doctor. He also admitted to forging Dr. Couch’s signature on prescriptions, and estimated he did this approximately 25,000 times over a four year period. Evidence at trial showed that both Dr. Couch and Dr. Ruan knew Palmer was forging Dr. Couch’s signature.  However, disciplinary action was never taken, and he was never reported to the nursing board. Palmer also testified that he was a habitual intravenous drug abuser, and that he was under the influence of very powerful opioids virtually every day while he was seeing and treating patients.

Based on his substantial assistance, including his testimony in the trial against Dr. Ruan and Dr. Couch, Palmer received a 50 percent sentence reduction recommendation from the United States.  The Court accepted this recommendation, and then sentenced Palmer to serve 30 months in federal prison for his criminal actions.

Bret Hamilton, DEA Assistant Special Agent-in-Charge for the State of Alabama, stated, “Justin Palmer had an honorable and promising career. His patients expected him to provide them with professional medical care. Instead of the welfare of his patients being the basis for his decision making process, his greed for financial gain and his illicit use of drugs guided him.”

Acting U.S. Attorney Steve Butler stated, “As Judge Granade observed at the sentencing hearing, Justin Palmer’s conduct was ‘beyond the pale.’ Forging a doctor’s name on a prescription is reprehensible, and even more so is the conduct of the doctors that let Palmer do this. That said, the United States recognizes that Palmer began cooperating even before the arrest of Dr. Couch and Dr. Ruan, and that his testimony was an important part of trial. Thus, the United States accepts the 30-month sentence handed down by the Court.”

In addition, Robert Laskey, Special Agent-in-Charge of the Federal Bureau of Investigation, Mobile Division, stated, “This type of behavior in the field of medicine cannot be tolerated by a doctor or an employee of the clinic. The FBI will continue to vigorously investigate these cases with a sense of urgency.”

This case was jointly investigated by DEA-Mobile and FBI-Mobile.    

Parents and children are encouraged to educate themselves about the dangers of drugs by visiting DEA’s interactive websites at www.JustThinkTwice.com, www.GetSmartAboutDrugs.com and www.dea.gov. 

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Steven L. Hofer Special Agent in Charge - New Orleans
@DEANewOrleans
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster